Yang Yang

Dr. Yang Yang

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2022 in Molecules
Verified
Journal Article
Open access
PDF file
YMYueguang Mi
Yueguang Mi
WHWandi Hu
Wandi Hu
WLWeiwei Li
Weiwei Li
SWShiyu Wan
Shiyu Wan
XXXiaoyan Xu
Xiaoyan Xu
DGDean Guo
Dean Guo
Wenxin granule (WXG) is a popular traditional Chinese medicine (TCM) preparation for the treatment of arrhythmia disease. Potent analytical technologies are needed to elucidate its chemical composition and assess the quality differences among multibatch samples. In this work, both a multicomponent characterization and quantitative assay of WXG were conducted using two liquid chromatography–mass spectrometry (LC-MS) approaches. An ultra-high performance liquid chromatography–ion mobility quadrupole time-of-flight mass spectrometry (UHPLC/IM-QTOF-MS) approach combined with intelligent peak annotation workflows was developed to characterize the multicomponents of WXG. A hybrid scan approach enabling alternative data-independent and data-dependent acquisitions was established. We characterized 205 components, including 92 ginsenosides, 53 steroidal saponins, 14 alkaloids, and 46 others. Moreover, an optimized scheduled multiple reaction monitoring (sMRM) method was elaborated, targeting 24 compounds of WXG via ultra-high performance liquid chromatography–triple quadrupole linear ion trap mass spectrometry (UHPLC/QTrap-MS), which was validated based on its selectivity, precision, stability, repeatability, linearity, sensitivity, recovery, and matrix effect. By applying this method to 27 batches of WXG samples, the content variations of multiple markers from Notoginseng Radix et Rhizoma (21) and Codonopsis Radix (3) were depicted. Conclusively, we achieved the comprehensive multicomponent characterization and holistic quality assessment of WXG by targeting the non-volatile components.

27 February 2023 in Molecules
Verified
Journal Article
Open access
PDF file
MZMoli Zhang
Moli Zhang
YYYang Yang
Yang Yang
LXLingyi Xin
Lingyi Xin
HZHua Zhang
Hua Zhang
LWLun Wu
Lun Wu
GYGuangyi Yang
Guangyi Yang
Recently, miRNAs have become a promising biomarker for disease diagnostics. miRNA-145 is closely related to strokes. The accuracy determination of miRNA-145 (miR-145) in stroke patients still remains challenging due to its heterogeneity and low abundance, as well as the complexity of the blood matrix. In this work, we developed a novel electrochemical miRNA-145 biosensor via subtly coupling the cascade strand displacement reaction (CSDR), exonuclease III (Exo III), and magnetic nanoparticles (MNPs). The developed electrochemical biosensor can quantitatively detect miRNA-145 ranging from 1 × 102 to 1 × 106 aM with a detection limit as low down as 100 aM. This biosensor also exhibits excellent specificity to distinguish similar miRNA sequences even with single-base differences. It has been successfully applied to distinguish healthy people from stroke patients. The results of this biosensor are consistent with the results of the reverse transcription quantitative polymerase chain reaction (RT-qPCR). The proposed electrochemical biosensor has great potential applications for biomedical research on and clinical diagnosis of strokes.

14 October 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
XWXiaoSuo Wang
XiaoSuo Wang
WLWei Yi Lew
Wei Yi Lew
YYYang Yang
Yang Yang
NZNan Zhang
Nan Zhang
JBJiexun Bu
Jiexun Bu
John O'SullivanJohn O'Sullivan
John O'Sullivan
Background/Objectives: Clozapine remains the gold standard for treatment-resistant schizophrenia. However, its narrow therapeutic window and risk of severe side effects require close monitoring of both clozapine and its primary metabolite, norclozapine. Existing therapeutic drug monitoring (TDM) methods are limited by delays, high costs, and operational complexity. This study introduces three rapid point-of-care (POC) assays utilizing a miniature mass spectrometer (Mini-MS) to quantify clozapine and norclozapine in plasma, whole blood, and dried blood spots (DBSs), facilitating applications across diverse clinical settings. Methods: The analytical performance of the assay was evaluated for sensitivity, specificity, reproducibility, and correlation with reference methods. Clinical samples from two hospitals were analysed and validated against conventional liquid chromatography tandem mass spectrometry (LC-MS/MS) reference standards at New South Wales Health Pathology (NSWHP) and Tsinghua University laboratories. Results: The Mini-MS assay accurately quantified both analytes within therapeutic ranges across all matrices. Inter-assay coefficients of variation ranged from 7.9 to 14.1% for clozapine and from 1.6 to 14.6% for norclozapine. Accuracy fell between 85 and 117% in plasma and blood extracts. Strong linearity was demonstrated (R2 = 0.98–0.99) over the concentration range of 10–1000 ng/mL. Results from the Mini-MS analysis showed excellent correlations with LC-MS/MS results (r = 0.998). Conclusions: In this proof-of-concept study, the Mini-MS-based POC assays enable rapid, reliable quantification of clozapine and norclozapine, with performance comparable to conventional laboratory methods. This platform supports real-time TDM, facilitating timely dose adjustments, adherence monitoring, and ultimately improving patient outcomes.

16 February 2026 in Materials & Design
Verified
Journal Article
Open access
YYYang Yang
Yang Yang
JLJingjian Liu
Jingjian Liu
JZJiye Zhang
Jiye Zhang
SZShuya Zhang
Shuya Zhang
JWJiazhen Wu
Jiazhen Wu
QCQinhua Chen
Qinhua Chen

3 August 2026 in Chemistry of Materials
Verified
Journal Article
Closed access
YYYang Yang
Yang Yang
DSDinping She
Dinping She
SZShuya Zhang
Shuya Zhang
HLHanHong Li
HanHong Li
QCQinhua Chen
Qinhua Chen
JZJiye Zhang
Jiye Zhang

28 March 2026 in Microchimica Acta
Verified
Journal Article
Closed access
PDF file
YWYue Wu
Yue Wu
YLYuan Li
Yuan Li
HZHua Zhang
Hua Zhang
LWLun Wu
Lun Wu
YWYan Wei
Yan Wei
QCQinhua Chen
Qinhua Chen